David Tatum

David Tatum


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MMMichael William Mara
Michael William Mara
DTDavid Tatum
David Tatum
AMAnne-Marie March
Anne-Marie March
GDGilles Doumy
Gilles Doumy
EMEvan G. Moore
Evan G. Moore
KRKenneth N. Raymond
Kenneth N. Raymond

19 February 2015 in Journal of the American Chemical Society
Verified
Journal Article
Open access
LDLena J. Daumann
Lena J. Daumann
DTDavid Tatum
David Tatum
BSBenjamin E. R. Snyder
Benjamin E. R. Snyder
CNChengbao Ni
Chengbao Ni
GLGa-Lai Law
Ga-Lai Law
KRKenneth N. Raymond
Kenneth N. Raymond
We report the preparation and new insight into photophysical properties of luminescent hydroxypyridonate complexes [MIIIL]− (M = Eu or Sm) of the versatile 3,4,3-LI(1,2-HOPO) ligand (L). We report the crystal structure of this ligand with EuIII as well as insights into the coordination behavior and geometry in solution by using magnetic circular dichroism. In addition TD-DFT calculations were used to examine the excited states of the two different chromophores present in the 3,4,3-LI(1,2-HOPO) ligand. We find that the EuIII and SmIII complexes of this ligand undergo a transformation after in situ preparation to yield complexes with higher quantum yield (QY) over time. It is proposed that the lower QY in the in situ complexes is not only due to water quenching but could also be due to a lower degree of f-orbital overlap (in a kinetic isomer) as indicated by magnetic circular dichroism measurements.

18 December 2014 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
DPDarpan N. Pandya
Darpan N. Pandya
SPSylvie Pailloux
Sylvie Pailloux
DTDavid Tatum
David Tatum
DMDarren Magda
Darren Magda
Thaddeus WadasThaddeus Wadas
Thaddeus Wadas
Octadentate terephthalamide ligands can be easily radiolabeled with 89Zr and are highly stable in vitro. They represent a novel class of bifunctional chelators for 89Zr.

13 September 2021 in EBioMedicine
Verified
Journal Article
Open access
AFAlexandra Foster
Alexandra Foster
SNShubhanchi Nigam
Shubhanchi Nigam
DTDavid Tatum
David Tatum
IRItay Raphael
Itay Raphael
JXJide Xu
Jide Xu
Gary KohanbashGary Kohanbash
Gary Kohanbash
Malignant gliomas are deadly tumours with few therapeutic options. Although immunotherapy may be a promising therapeutic strategy for treating gliomas, a significant barrier is the CD11b+ tumour-associated myeloid cells (TAMCs), a heterogeneous glioma infiltrate comprising up to 40% of a glioma's cellular mass that inhibits anti-tumour T-cell function and promotes tumour progression. A theranostic approach uses a single molecule for targeted radiopharmaceutical therapy (TRT) and diagnostic imaging; however, there are few reports of theranostics targeting the tumour microenvironment. Utilizing a newly developed bifunctional chelator, Lumi804, an anti-CD11b antibody (αCD11b) was readily labelled with either Zr-89 or Lu-177, yielding functional radiolabelled conjugates for PET, SPECT, and TRT. 89Zr/177Lu-labeled Lumi804-αCD11b enabled non-invasive imaging of TAMCs in murine gliomas. Additionally, 177Lu-Lumi804-αCD11b treatment reduced TAMC populations in the spleen and tumour and improved the efficacy of checkpoint immunotherapy. 89Zr- and 177Lu-labeled Lumi804-αCD11b may be a promising theranostic pair for monitoring and reducing TAMCs in gliomas to improve immunotherapy responses. A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

7 March 2014 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JPJoseph I. Pacold
Joseph I. Pacold
DTDavid Tatum
David Tatum
GSGerald T. Seidler
Gerald T. Seidler
KRKenneth N. Raymond
Kenneth N. Raymond
XZXiaoyi Zhang
Xiaoyi Zhang
DMDevon R. Mortensen
Devon R. Mortensen

17 December 2015 in Inorganic Chemistry
Verified
Journal Article
Closed access
LDLena J. Daumann
Lena J. Daumann
DTDavid Tatum
David Tatum
CAChristopher M. Andolina
Christopher M. Andolina
JPJoseph I. Pacold
Joseph I. Pacold
ADAnthony D’aléo
Anthony D’aléo
KRKenneth N. Raymond
Kenneth N. Raymond